tirzepatide fda label Grants a New Indication for Obesity Management Tirzepatide Is Generic for What?
Description
A recent study from the Mayo Clinic reveals that postmenopausal women undergoing hormone therapy experience significantly more weight loss when treated with semaglutide, a popular anti-obesity drug, compared to those not on hormone therapy
*In the hair regrowth category
In the above resource, the guest expert, Dr
Side effect bother was measured with the Functional Assessment of Chronic Illness Therapy (FACIT) GP5 item
